Literature DB >> 30307383

Low-dose CT screening for lung cancer reduced lung cancer mortality in Hitachi City.

Takeshi Nawa1.   

Abstract

Purpose: To detect early, curable lung cancer, screening using low-dose CT (CT screening) was initiated in Japan and Western countries around the early 1990s. Material and methods: In 2013, the National Lung Screening Trial (NLST) reported that annual CT screening for high-risk participants leads to a 16% reduction in lung cancer death. In Hitachi City, CT screening for citizens 50 years of age or older was started in 1998, and 30% of the citizens had received a CT examination at least once by 2006.
Results: We reported excellent survival (5-year survival of 90%) of 210 patients with lung cancer detected by CT screening. Based on a time trend analysis, a significant reduction (24%) in lung cancer mortality was observed 4 to 8 years after the introduction of CT screening among Hitachi residents. CT images can detect numerous smoking-related factors represented by pulmonary emphysematous change (CT emphysema). If we can evaluate the risk of respiratory disease according to these images, the benefits of screening are expected to increase further.
Conclusion: To establish the effectiveness of CT screening for the general population, an optimum screening schedule is desired based on the risk of individuals. In addition, long-term follow-up is necessary to evaluate the effects of radiation exposure.

Entities:  

Keywords:  Low-dose CT; lung cancer; mortaliy reduction; screening

Year:  2018        PMID: 30307383     DOI: 10.1080/09553002.2018.1511930

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  7 in total

1.  Interventions of Advanced Lung Cancer Patient Receiving Chemotherapy by Computed Tomography Image Information Data Analysis-Based Soothing Care Plans.

Authors:  Juan Wang; Shuangping Lu; Qundan Zhang
Journal:  Comput Math Methods Med       Date:  2022-06-09       Impact factor: 2.809

2.  Lung Cancer Screening With Low-dose Chest Computed Tomography: Experience From Radon-contaminated Regions in Kazakhstan.

Authors:  Alexandra Panina; Dilyara Kaidarova; Zhamilya Zholdybay; Akmaral Ainakulova; Jandos Amankulov; Dias Toleshbayev; Zhanar Zhakenova; Arman Khozhayev
Journal:  J Prev Med Public Health       Date:  2022-04-14

3.  Liriopesides B induces apoptosis and cell cycle arrest in human non‑small cell lung cancer cells.

Authors:  Hongxu Sheng; Wang Lv; Linhai Zhu; Luming Wang; Zhitian Wang; Jia Han; Jian Hu
Journal:  Int J Mol Med       Date:  2020-06-16       Impact factor: 4.101

4.  Deep Learning-Based Chest CT Image Features in Diagnosis of Lung Cancer.

Authors:  Jianxin Feng; Jun Jiang
Journal:  Comput Math Methods Med       Date:  2022-01-19       Impact factor: 2.238

5.  Lung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international meta-analysis.

Authors:  John K Field; Daniel Vulkan; Michael P A Davies; David R Baldwin; Kate E Brain; Anand Devaraj; Tim Eisen; John Gosney; Beverley A Green; John A Holemans; Terry Kavanagh; Keith M Kerr; Martin Ledson; Kate J Lifford; Fiona E McRonald; Arjun Nair; Richard D Page; Mahesh K B Parmar; Doris M Rassl; Robert C Rintoul; Nicholas J Screaton; Nicholas J Wald; David Weller; David K Whynes; Paula R Williamson; Gasham Yadegarfar; Rhian Gabe; Stephen W Duffy
Journal:  Lancet Reg Health Eur       Date:  2021-09-11

6.  A novel signature based on autophagy-related lncRNA for prognostic prediction and candidate drugs for lung adenocarcinoma.

Authors:  Zetian Gong; Qifan Li; Jun Li; Jiaheng Xie; Wei Wang
Journal:  Transl Cancer Res       Date:  2022-01       Impact factor: 1.241

7.  Screening for Lung Cancer: CHEST Guideline and Expert Panel Report.

Authors:  Peter J Mazzone; Gerard A Silvestri; Lesley H Souter; Tanner J Caverly; Jeffrey P Kanne; Hormuzd A Katki; Renda Soylemez Wiener; Frank C Detterbeck
Journal:  Chest       Date:  2021-07-13       Impact factor: 9.410

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.